BMJ

The Copenhagen Hip and Groin Outcome Score (HAGOS): development and validation according to the COSMIN checklist

2 Research Unit for Musculoskeletal Function and Physiotherapy, Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark 3 The Parker Institute: ...
Morningstar

Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial

iPercent change in the WOMAC pain subscale score and percent change in the WOMAC physical function subscale score were not pre-specified and were estimated from a post-hoc analysis. iiNot controlled ...
Clinical Advisor

TRIUMPH-4 Results: Retatrutide Cuts Weight and Knee OA Pain

Retatrutide treatment resulted in significant improvements in WOMAC pain scores and body weight compared with placebo in the TRIUMPH-4 trial.
Cochrane

How well does the State-Trait Anxiety Inventory (STAI) identify anxiety disorders?

it tends to identify individuals with anxiety disorders, but may also incorrectly label many people who do not have anxiety; the included studies varied in quality, and mostly involved people from ...
The New England Journal of Medicine

A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia

An oral compound, SEP-363856, that does not act on dopamine D2 receptors but has agonist activity at trace amine–associated receptor 1 (TAAR1) and 5-hydroxytryptamine type 1A (5-HT 1A) receptors, may ...